Please assess the completion status of the following clinical trial:

Trial Title: PK Driven Prophylaxis for Hemophilia A

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male Patient~* Severe or moderately severe haemophilia A (FVIII = 2 %), preventively treated (processing) by ADVATE for at least 6 months,~* At last 6 years old,~* An informed consent must be signed by the patient or his legal representative for the patients minor.~* Affiliated to a national insurance scheme~Exclusion Criteria:~* Previous or actual treatment with FVIII inhibitors \> 0,6 UB at the selection~* Induction of immune tolerance~* Planned orthopedic surgery for the 18 next months~* Any other haemostatic pathology~* Any treatment interacting on the haemostasis~* Patient under guardianship~* Patient participating in another biomedical research

- Gender: MALE
- Minimum Age: 6 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MyPKFiT (Type: EXPERIMENTAL): Personalized prophylaxis : Treatment is adjustment according to PK modeling

Based on this trial design, predict the completion outcome and termination type (if applicable).